HYTN Innovations Inc. (HYTNF)
| Market Cap | 14.90M -32.5% |
| Revenue (ttm) | 2.66M +194.3% |
| Net Income | -1.25M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.1538 |
| Previous Close | 0.1538 |
| Day's Range | 0.1538 - 0.1538 |
| 52-Week Range | 0.0675 - 0.2500 |
| Beta | 3.95 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 29, 2027 |
About HYTN Innovations
HYTN Innovations Inc. engages in the export and sale of cannabis products in Canada and Australia. The company offers edible cannabis, cannabis beverages, and cannabis flowers. The company is based in Kelowna, Canada. [Read more]
Financial Performance
In fiscal year 2025, HYTN Innovations's revenue was 1.67 million, an increase of 96.58% compared to the previous year's 851,494. Losses were -1.52 million, -77.06% less than in 2024.
Financial numbers in CAD Financial StatementsNews
HYTN Announces Arrangement Agreement to Facilitate the Spin-Out of a Peptide-Focused Drug Development Business
VANCOUVER, British Columbia, Sept. 02, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in p...
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in pro...
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in p...
HYTN Announces Extension of Marketing Program
VANCOUVER, British Columbia, April 24, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in c...
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has appr...
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
VANCOUVER, British Columbia, April 17, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in p...
HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
VANCOUVER, British Columbia, March 27, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in p...
HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in c...
HYTN Announces Engagement of Marketing and Communications Services Provider
VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in ca...
HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical-grade cannabis manufacturer, ac...
HYTN Receives Initial International Purchase Order for GMP Vape Cartridges
VANCOUVER, British Columbia, June 11, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufa...
HYTN Receives GMP Certificates for The United States, Bermuda and Israel
VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manuf...
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market
VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manuf...
HYTN Launches GMP Stability Program and Validates Vape Cartridges for International Markets
VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufa...
HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products
VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade c...
HYTN and SNDL to Collaborate on GMP-Compliant Vape Cartridge Development for Global Markets
VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade c...
HYTN Secures Additional Permits to Expand International GMP Cannabis Exports
VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmac...
HYTN Announces Initial Purchase Order under Manufacturing Partnership with Industry-Leading SNDL
VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical company specializing in pharmac...
HYTN Receives Opening Order and Import Permits from the UK's 4C Labs, Prepares Products for Export
VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the dev...
HYTN Announces Marketing Program
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a company specializing in the pharmaceutical dev...
HYTN Expands GMP Capabilities with New Licensed Activity
HYTN receives certification for GMP distribution to international markets HYTN receives certification for GMP distribution to international markets
HYTN Files Business Acquisition Report
VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or “the Company”), a pharmaceutical company specializing in the de...